Table of Contents
Volume 7 | Supplement 1
Publication Date: September 2005- Abstract
- No Access
- Pay-Per View
- Full Text
- Add to Cart
Introduction | ||
S4-S5 |
Emerging Novel Agents with Utility in Non-Small-Cell Lung Cancer Chandra P. Belani |
|
Contributions | ||
S6-S12 |
Activity of Novel Cytotoxic Agents in Lung Cancer: Epothilones and Topoisomerase I Inhibitors Heather A. Wakelee, Branimir I. Sikic |
|
S13-S18 |
Current Status of Mammalian Target of Rapamycin Inhibitors in Lung Cancer Carlos Gómez-Martín, Belen Rubio-Viqueira, Manuel Hidalgo |
|
S19-S30 |
Histone Deacetylase Inhibitors: Emerging Anticancer Therapeutic Agents Rebecca Kristeleit, Peter Fong, G. Wynne Aherne, Johann de Bono |
|
S31-S38 |
Targeting Angiogenesis with Vascular Endothelial Growth Factor Receptor Small-Molecule Inhibitors: Novel Agents with Potential in Lung Cancer Heather A. Wakelee, Joan H. Schiller |
|
S39-S44 |
Targeting Multiple Signal Transduction Pathways in Lung Cancer Alex A. Adjei |
|